Search Results - "Olydam, Jill"

Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action by Logger, Jade G.M., Olydam, Jill I., Driessen, Rieke J.B.

“…Flushing and erythema are frequent skin symptoms in rosacea. Because their adequate treatment remains a clinical challenge, new treatment options are explored,…”
Get full text

EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab by Olydam, Jill I., de Wijs, Linde E.M., Dik, Willem A., Røpke, Mads A., Da Rosa, Joel Correa, Hijnen, Dirk Jan

Get full text

A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council by Haag, Carter, Alexis, Andrew, Aoki, Valeria, Bissonnette, Robert, Blauvelt, Andrew, Chovatiya, Raj, Cork, Michael J, Danby, Simon G, Eichenfield, Lawrence F, Eyerich, Kilian, Gooderham, Melinda, Guttman-Yassky, Emma, Hijnen, Dirk-Jan, Irvine, Alan D, Katoh, Norito, Murrell, Dedee F, Leshem, Yael A, Levin, Adriane A, Vittrup, Ida, Olydam, Jill I, Orfali, Raquel L, Paller, Amy S, Renert-Yuval, Yael, Rosmarin, David, Silverberg, Jonathan I, Thyssen, Jacob P, Ständer, Sonja, Stefanovic, Nicholas, Todd, Gail, Yu, JiaDe, Simpson, Eric L

Get full text

Anatomical site variation of water content in human skin measured by the Epsilon: A pilot study by Logger, Jade G M, Münchhoff, Christina U, Olydam, Jill I, Peppelman, Malou, Van Erp, Piet E J

“…This pilot study aimed to investigate the anatomical site variation of water content of the stratum corneum (SC) on the body by measuring skin capacitance with…”
Get more information

Adjusted dose regimens in dupilumab treatment for atopic dermatitis: Daily practice experiences by Olydam, Jill I., Wijs, Linde E. M., Nijsten, Tamar E. C., Rosmalen, Joost, Hijnen, Dirk Jan

“…Background Clinical trials with dupilumab in atopic dermatitis (AD) patients showed a trend towards better effectiveness with a weekly or biweekly dosing…”
Get full text

Noninvasive Skin Barrier Assessment: Multiparametric Approach and Pilot Study by Logger, Jade, Olydam, Jill, Woliner-van der Weg, Wietske, van Erp, Piet

“…The epidermal barrier function is disrupted in various inflammatory skin diseases. Accurate methods to measure skin barrier function are needed to assess the…”
Get full text

Prediction of response to dupilumab treatment by Hijnen, DirkJan, Olydam, Jill

Get full text

Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practice by Schlösser, Anne R, Shareef, Madena, Olydam, Jill, Nijsten, Tamar E C, Hijnen, Dirk Jan

“…Evidence about tralokinumab treatment for moderate-to-severe atopic dermatitis (AD) in daily practice is limited. To report the first evidence, to our…”
Get full text

Upadacitinib treatment in a real‐world difficult‐to‐treat atopic dermatitis patient cohort by Schlösser, Anne R., Boeijink, Neill, Olydam, Jill, Nijsten, Tamar E. C., Hijnen, DirkJan

“…Background Upadacitinib was the first JAK‐1 selective inhibitor registered for the treatment of moderate‐to‐severe atopic dermatitis (AD). Although efficacy…”
Get full text

A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council by Haag, Carter, Alexis, Andrew, Aoki, Valeria, Bissonnette, Robert, Blauvelt, Andrew, Chovatiya, Raj, Cork, Michael J, Danby, Simon G, Eichenfield, Lawrence, Eyerich, Kilian, Gooderham, Melinda, Guttman-Yassky, Emma, Hijnen, Dirk-Jan, Irvine, Alan, Katoh, Norito, Murrell, Dedee F, Leshem, Yael A, Levin, Adriane, Vittrup, Ida, Olydam, Jill I, Orfali, Raquel L, Paller, Amy, Renert-Yuval, Yael, Rosmarin, David, Silverberg, Jonathan, Thyssen, Jacob, Ständer, Sonja, Stefanovic, Nick, Todd, Gail, Yu, JiaDe, Simpson, Eric

“…Janus kinase inhibitors (JAKinibs) have the potential to dramatically alter the landscape of atopic dermatitis (AD) management due to their promising efficacy…”
Get full text